Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Singular Genomics Systems, Inc.

Get SEC filing alerts via email and in your feed for Singular Genomics Systems, Inc.

OMIC

Singular Genomics Systems, Inc.

About Singular Genomics Systems, Inc.

Singular Genomics Systems develops next-generation sequencing and spatial multiomics technologies. Its G4 platform offers fast, accurate benchtop genomic sequencing, while the G4X Spatial Sequencer enables in situ tissue analysis of RNA, proteins, and histology with high throughput. The company targets research, life sciences, and biopharmaceutical markets, leveraging proprietary chemistry and hardware to advance biological discovery and translational medicine.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from Singular Genomics Systems, Inc.

1
1
Singular Genomics Systems, Inc. Singular Genomics Reports Continued Net Losses and Declining Revenues in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments